ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ANTX AN2 Therapeutics Inc

2.56
0.17 (7.11%)
May 02 2024 - Closed
Delayed by 15 minutes

AN2 Therapeutics Financial Summary

The current ANTX market cap is 76.14M. The company's latest EPS is USD -2.1765 and P/E is -1.16.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -11.77M-12.48M-16.04M-16.6M-18.18M
Net Income -11.34M-11.84M-15.32M-15.8M-16.71M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -21.61M-42.26M-69.64M
Net Income -28.06M-42.78M-64.73M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Assets 110.01M102.56M91.08M98.93M153.81M
Total Liabilities 4.44M7.19M8.57M11.16M14.84M
Total Equity 105.57M95.37M82.52M87.76M138.97M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 65.32M102.56M138.74M
Total Liabilities 3.41M7.19M14.04M
Total Equity -47.41M95.37M124.7M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Operating -25.82M-33.46M-11.6M-24.42M-36.22M
Investing -27.83M-21.77M10.89M18.76M-43.7M
Financing 70.36M70.36M199k19.25M85.32M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -20.48M-33.46M-53.29M
Investing -50.02M-21.77M-43.28M
Financing 78.54M70.36M84.99M
Market Cap 76.14M
Price to Earnings Ratio -1.16
Price to Sales Ratio 0
Price to Cash Ratio 4.81
Price to Book Ratio 0.6
Dividend Yield -

Share Statistics

Shares Outstanding 29.74M
Average Volume (1 week) 103.34k
Average Volume (1 Month) 321.22k
52 Week Change -67.22%
52 Week High 22.22
52 Week Low 2.20
Spread (Intraday) 0.18 (6.92%)

Company Info

Company Name AN2 Therapeutics Inc
Address 850 new burton road
dover, delaware 19904
Website https://www.an2therapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock